Literature DB >> 20458450

Snapshot of the interaction between HIV envelope glycoprotein 120 and protein disulfide isomerase.

Zhiqiang Wang1, Zhimin Zhou, Zhan-Yun Guo, Cheng-Wu Chi.   

Abstract

The human immunodeficiency virus-1 (HIV-1) envelope glycoprotein 120 (gp120) binds to cell surface receptors and mediates HIV entry. Previous studies suggest the cell surface protein disulfide isomerase (PDI) might interact with disulfide bond(s) of gp120 and thus facilitate HIV-1 entry. In the present study, a kinetic trapping approach was used to capture the disulfide cross-linking intermediate between gp120 and PDI. Active site mutant PDIs were prepared in which the C-terminal cysteine at the active site was replaced by a serine. The active site mutant PDIs were able to covalently cross-link with gp120 through a mixed disulfide bond in vitro. The cross-linking efficiency was enhanced by CD4 protein (primary receptor of HIV-1) and was inhibited both by bacitracin (a PDI inhibitor) and by catalytically inactive PDI. The present results suggested the cell surface PDI might play a role in HIV entry in vivo.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20458450     DOI: 10.1093/abbs/gmq024

Source DB:  PubMed          Journal:  Acta Biochim Biophys Sin (Shanghai)        ISSN: 1672-9145            Impact factor:   3.848


  3 in total

Review 1.  Candidate antibody-based therapeutics against HIV-1.

Authors:  Rui Gong; Weizao Chen; Dimiter S Dimitrov
Journal:  BioDrugs       Date:  2012-06-01       Impact factor: 5.807

2.  Cell-type specific requirements for thiol/disulfide exchange during HIV-1 entry and infection.

Authors:  Tzanko S Stantchev; Mark Paciga; Carla R Lankford; Franziska Schwartzkopff; Christopher C Broder; Kathleen A Clouse
Journal:  Retrovirology       Date:  2012-12-03       Impact factor: 4.602

3.  Proteomics based identification of cell migration related proteins in HBV expressing HepG2 cells.

Authors:  Huixing Feng; Xi Li; Vincent Chan; Wei Ning Chen
Journal:  PLoS One       Date:  2014-04-24       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.